RasP Gene Expression for Protein Secretion in Bacillus subtilis

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for improving protein production and secretion in Gram-positive bacterial cells, such as Bacillus subtilis, are limited by the degradation of essential proteins like PrsA, which hampers efficient protein secretion and industrial use.

Innovation Solution

Modifying Gram-positive bacterial cells to over-express the rasP gene, encoding the regulating anti-sigma factor protease (RasP), by substituting the native promoter with a more active one like the spoVG or aprE promoter, or modifying the 5'-untranslated region, to enhance protein production and secretion.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If the native promoter is used to express rasP gene, then the cell maintains normal physiological function, but protein production remains limited

Engineering Contradiction:
Improveprotein productionVSAvoidprotein secretion efficiency
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The patent applies parameter changes by substituting the native promoter with a stronger, more active promoter (such as spoVG or aprE promoters) to drive higher expression levels of the rasP gene. This increases the production of RasP protease, which in turn enhances protein secretion efficiency and overall productivity of the bacterial cell factory system.

Inventive Principle:
Principle #35Parameter changes

2Productivity

If PrsA is overexpressed to improve protein folding, then secretion efficiency increases, but PrsA is degraded by WprA and other proteases, reducing its suitability for industrial use

Engineering Contradiction:
Improveprotein secretionVSAvoidstability of essential proteins
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The patent uses RasP protease as an intermediary to indirectly enhance protein secretion. Instead of directly overexpressing PrsA (which gets degraded), the system overexpresses RasP to regulate and optimize the secretion machinery, thereby improving protein export without the stability issues associated with PrsA overexpression.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Productivity

If signal peptide composition is optimized to improve secretion, then protein export increases, but the complexity of optimization targets increases

Engineering Contradiction:
Improveprotein secretionVSAvoidoptimization complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The patent extracts and addresses the root cause limiting protein secretion by focusing on the rasP gene expression. Rather than optimizing multiple parameters simultaneously (signal peptides, SRP, translocation machinery, signal peptidases), the invention identifies and enhances the key regulatory factor (RasP) that controls the secretion efficiency, thereby simplifying the optimization process.

Inventive Principle:
Principle #2Taking out (Extraction)

Data Source

PatentEP3380496B1Enhanced protein production and methods thereof
Publication Date: 2020.05.20 DANISCO US INC
  • EP3380496B1 patent drawingFigure 1A
  • EP3380496B1 patent drawingFigure 1B
  • EP3380496B1 patent drawingFigure 2A

AI summary

The present disclosure is generally related to modified Gram-positive bacterial cells producing increased amounts of one or more protein(s) of interest. Certain embodiments of the instant disclosure are therefore directed to modified Gram-positive bacterial cells expressing an increased amount of a POI relative to unmodified (i.e., parental) Gram-positive bacterial cells, wherein the modified (i.e., daughter) bacterial cells comprise a modification which increases rasP gene expression. In certain other embodiments, the disclosure pertains to methods of modifying bacterial cells such that the modified (daughter) cells produce an increased level of a protein of interest. In other embodiments, the disclosure pertains to a protein of interest produced by fermenting a modified bacterial cell of the instant disclosure. Certain other embodiments of the disclosure are directed to one or more proteinaceous compositions comprising one or more protein(s) of interest thus made.